Cargando…
Is there an inherent limit to acute migraine treatment efficacy?
Autores principales: | Bigal, Marcelo E., Ho, Tony W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476204/ https://www.ncbi.nlm.nih.gov/pubmed/19820895 http://dx.doi.org/10.1007/s10194-009-0162-y |
Ejemplares similares
-
Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment
por: Tfelt-Hansen, Peer C.
Publicado: (2009) -
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine
por: Krymchantowski, Abouch Valenty, et al.
Publicado: (2004) -
Overview on the prevalence and impact of migraine
por: Bigal, Marcelo E., et al.
Publicado: (2004) -
Migraine and behavior in children: influence of maternal headache frequency
por: Arruda, Marco A., et al.
Publicado: (2012) -
Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders
por: Krymchantowski, Abouch Valenty, et al.
Publicado: (2011)